Tumor Necrosis Factor α from Peripheral Blood Mononuclear Cells of IgA Nephropathy and Mesangial Cell Proliferation

Article information

Korean J Intern Med. 1994;9(1):1-8

doi : https://doi.org/10.3904/kjim.1994.9.1.1

Tae-Won Lee, M.D., Jae-Hyung Ahn, M.D., Jae-Kyung Park, M.D., Chun-Gyoo Ihm, M.D., Myung-Jae Kim, M.D.

Department of Internal Medicine/Nephrology, Kyung-Hee University College of Medicine, Seoul, Korea

Address reprint requests to: Tae Won Lee, M.D., Department of Internal Medicine Kyung-Hee University Medical Center, # Hoekidong, Dong-daemunku, Seoul, 130-702, Korea

Abstract

Background

To investigate the role of mononuclear cells and their products on rat mesangial cell proliferation, we evaluated the effect of peripheral blood mononuclear cells (PBMC) culture supernatant of patients with IgA nephropathy on rat mesangial cells ³[H]-thymidine uptake, and measured the concentration of cytokines in the supernatant to find out which cytokine in PBMC culture supernatant has a major influence on mesangial cell ³[H]-thymidine uptake.

Methods:

In ten patients with primary IgA nephopathy and 10 normal controls, PBMC were cultured with PHA (20 μg/ml) and con-A (10 μg/ml) for 24 hours, and supernatants were collected and stored at −70°C until tested. Mesangial cell was cultured for 48 hours at a concentration of 10⁴ cells/well with 1:2 or 1:10 diluted PBMC culture supernatant. ³[H]-thymidine uptake into rat mesangial cell was assayed after 18 hour culture. The cytokine concentrations of PBMC culture supernatant were measured by radioimmunoassay.

Results:

When 1:2 diluted PBMC culture supernatant was added, the supernatant of IgA nephropathy induced higher ³[H]-thymidine uptake into mesangial cell compared with that of normal controls. ³[H]-thymidine uptake induced by 1:2 diluted PBMC culture supernatant was significantly higher than that induced by 1:10 diluted supernatant of IgA nephropathy. The concentration of TNF-α in PBMC culture supernatant of the patients with IgA nephropathy was higher than that of normal controls and showed a good correlation with the mesangial cell ³[H]-thymidine uptake.

Conclusion:

It is suggested that the mononuclear cell of IgA nephropathy may have the intrinsic property to produce more TNF-α which may be mitogenic to mesangial cells when stimulated with mitogens, and it may be related to the mesangial cell proliferation in IgA nephropathy.

Keywords: Tumor necrosis factor; IgA nephropathy; Mesangial cell proliferation

INTRODUCTION

IgA nephropathy is one of the most common primary glomerulonephritis in the world, including Korea^1–4). The main histologic feature is the mesangial cell proliferation, which suggests the role of cytokines and growth factors in its pathogenesis⁵⁾. Cytokines and growth factors are known to be derived from intrinsic glomerular cells and/or infiltrating inflammatory cells⁵⁾. Among the infiltrating cells, monocytes, which are known to be the principal effectors cells in immune mediated nephritis, frequently infiltrate the glomerular mesangium⁶⁾, and their cytokines are revealed to stimulate the mesangial cell proliferation. Among them, interleu-kin-1 (IL-1), tumor necrosis factor α (TNF α) and interleukin-6 (IL-6) are primarily released by activated monocytes/macrophages^5,7).

To investigate the role of mononuclear cells and their products on rat mesangial cell proliferation, we evaluated the effect of mitogen-stimulated PBMC culture supernatant of patients with IgA nephropathy on rat mesangial cell ³[H]-thymidine uptake and measured the concentration of cytokines in the supernatant to know which cytokine in PBMC culture supernatant has a major influence on mesangial cell ³[H]-thymidine uptake.

ATERIALS AND METHODS

1. Subjects

PBMC were isolated and cultured from ten patients with primary IgA nephropathy and from ten normal controls. The clinical and laboratory characteristics of the patients whose PBMC were isolated and cultured were shown in Table 1. The diagnosis of IgA nephropathy was based on the presence of predominant mesangial immunofluorescent IgA deposits and mesangial and paramesangial electron-dense deposits in renal biopsy specimens. Patients with the clinical and laboratory evidences of hepatic disease, systemic lupus erythematosus, Henoch-schoenlein nephritis and other systemic diseases were excluded. No patient had renal insufficiency or nephritic syndrome and all patients were in clinically quiescent state without fever, gross hematuria and upper respiratory or gastrointestinal illness. No Patients had infection or was on corticosteroid or immunosuppressive treatment within at least on month or entry into the study.

Table 1.

Characteristics of Patients with IgA Nephropathy

Medical doctors and nurses, matched for age and sex with the patients with IgA nephropathy, were selected as normal controls.

2. Preparation of PBMC Culture Supernatant

PBMC were isolated by Ficoll-Hypaque density gradient method⁸⁾ from heparinized venous blood in patients with IgA nephropathy and healthy controls. The cell suspension recovered at the interface was resuspended in RPMI 1640 at a concentration of 5×10⁶ cells/ml. The cells were stimulated with phytohemaglutinin (20 μg/ml) and concanavalin A (10 μg/ml). The PBMC were cultured at 37°C in a 5% CO₂ for 24 hours. After 24 hours, the supernatant was collected and stored at −70°C until tested.

3. Preparation of Mesangial Cell Culture

Kidneys from Spragde-Dawley rats weighing 100 to 150 g were removed. The cortex was minced into small pieces and passed through a series of steel sieves. The glomeruli collected on the top of the 75 μm sieve were rinsed with HBSS and were digested with 1 ml type IV collagense (GIBCO, NY, USA) at 37°C for 30 minutes with shaking. After centrifugation, the pellet was suspended in DMEM and plated into a tissue culture flask containing DMEM supplemented with 17% fetal calf serum (FCS), 100 U/ml penicillin, 100 μg/ml streptomycin, 10μg/ml insulin and L-glutamine. After three or four passages, no endothelial or epithelial cells were seen and the cultures consisted exclusively of mesangial cells. The mesangial cells were characterized by using phase contrast microscopy and the cells had prominent intracellular myosin fibrils and were negative with antibodies (Becton Dickinson, Mountain View, CA, USA) to common leukocyte antigen and Factor VIII by immunofluorescent staining⁹⁾. The cells were capable of growth in D-valine substituted medium and were not sensitive to puromycin.

4. Assay for Mesangial Cell ³[H]-thymidine Uptake

The number of mesangial cells was adjusted into 10⁵ cells/ml in DMEM containing 15% FCS and 10 μg/ml insulin and plated into 96 well microplate at a concentration of 10⁴ cells/well. After culture in a 5% CO₂ at 37°C for 48 hours, the medium was changed with DMEM containing diluted (1:2 or 1:10) PBMC culture supernatant and incubated for 24 hours. 1 μCi of ³[H]-thymidine (New England Nuclear, MA, USA) was pulsed to each well and the culture was incubated for 18 hours. After washing the cells with PBS, the cells were harvested and the radioactivity of incorporated ³[H]-thymidine was counted under γ-scintillation counter (Beckman 800, Irvine, CA, USA).

5. Lymphocyte Subsets and Natural Killer (NK) Cell Activity Measurement

Assay for the lymphocyte subsets was done by the method of indirect immunofluorescence (IF) using monoclonal antibodies (Becton Dickinson, CA, USA). 100 μl of the lymphocyte suspension adjusted to 5×10⁶ cells/ml were placed in plastic tubes (Costar 2022, MA, USA) and incubated with 20 μl of anti-leu-2a, anti-leu-3a, anti-leu-4, and anti-leu-12 for 30 minutes at 4°C respectively. After incubation, the cells were washed twice in PBS and labeled with 100 μl of mounting medium (PBS, pH 7. 4, containing 30% glycerol) was added to cell suspension and one drop was examined under fluorescence microscope (Olympus, type BH-2, Japan).

NK cell activity was assayed by a chromium-release method of Jondal et al¹⁰⁾. K-562 cells derived from a patient with chronic myeloid leukemia were used as target cells. Target cells were suspended at a concentration of 5×10⁶ cells/ml in complete culture medium and 100 μCi of Na₂⁵¹CrO₄ (New England Nuclear, MA, USA) was added to the 0.5 ml of cell suspension. After incubation for 90 minutes at 37°C in a 5% CO₂ in air, cells were washed three times with culture medium and 10 μl of cell suspension adjusted to 5×10⁶ cells/ml in complete culture medium were placed into 96-well microplate (Costar 3799, MA, USA). 200 μl of effectors peripheral blood lymphocyte adjusted to the concentration of 1×10⁶ cell/ml were added to target cells in triplicate with the ratio of lymphocyte to target cell of 40:1. Target cells were incubated in complete culture medium as controls for spontaneous release (SR), and maximum release (MR) was measured after the addition of 1% Triton X-100 solutions. Samples were counted in a gamma-counter (Gamma 5500; Beckman, CA, USA). Percent cytotoxicity was calculated with the previous formula⁵²⁾.

6. Cytokine Assay

The concentrations of IL-1 β, IL-2, TNF α, PDGF and IFN-γ were measured by using a commercially available radioimmunoassay kit (IL-1 β, IL-2, TNF α, PDGF: Amersham, USA, IFN-γ: Centocor, PA, USA).

7. Statistical Analysis

The results are expressed as mean ± SEM. Student’s t-test was used to compare the means of two groups. A p-value less than 0.05 was interpreted to be significant.

RESULTS

1. Effect of PBMC Culture Supernatant on Rat Mesangial Cell ³[H]-thymidine Uptake

The PBMC culture supernatant of the patients with IgA nephropathy induced the higher ³[H]-thymidine uptake into mesangial cell (37297±2421 cpm) compared with that of normal controls (30957±2469 cpm) when 1:2 diluted PBMC culture supernatant of the patients with IgA nephropathy and normal controls was added to the mesangial cell culture medium (Table 2, Fig. 1). However, the addition of 1:10 diluted supernatant into mesangial cell culture didn’t show any difference in ³[H]-thymidine uptake between IgA nephropathy and normal controls (Table 2, Fig. 1). The uptake of ³[H]-thymidine into mesangial cell induced by 1:2 diluted PBMC culture supernatant was significantly higher than that induced by 1:10 diluted supernatant in IgA nephropathy (37297±2421 cpm vs 27459±2025 cpm, P=0.0076). This difference, however, was not observed in normal controls (Table 2, Fig.1).

Table 2.

Effects of PBMC Culture Supernatant on Rat Mesangial Cell ³H-Thymidine Uptake (cpm)

Fig. 1.

Effects of PBMC culture supernatant on rat mesangial cell ³[H]-thymidine uptake.

IgAN; IgA nephropathy, Normal C; normal control.

2. The Concentration of Cytokines in PBMC Culture Supernatant

The concentration of TNF α in PBMC culture supernatant of patients with IgA nephropathy was significantly higher than that of normal controls (136.1±35.0 fmol/L vs 28.2±19.0 fmol/L, p<0.05). Moreover, the concentration of TNF α was significantly correlated with the mesangial cell ³[H]-thymidine uptake in patients with IgA nephropathy (r=0.61, p = 0.002) (Fig. 3). The concentration of IL -1β, IL-2, IFN-γ, and PDGF was higher in PBMC culture supernatant of patients with IgA nephropathy compared with that of normal controls. However, no statistical significance was observed (Fig. 2).

Fig. 3.

Correlation between concentrations of TNF α in PBMC culture supernatant and mesangial cell ³[H]-thymidine uptake.

Fig. 2.

The concentrations of cytokines in PBMC culture supernatant.

3. Lymphocyte Subsets and NK Cell Activity

When the lymphocyte subsets in patients with IgA nephropathy were compared with that in normal controls, the percentages of CD3 and CD8 cell were significantly lower in patients with IgA nephropathy than those in normal controls, and the percentages of B cells and NK cell activity were significantly higher in patients with IgA nephropathy than those in normal controls (Table 3). Because the percentages of CD3 cell were low in patients with IgA nephropathy, the CD4/CD8 ratio was significantly higher in patients with IgA nephropathy compared with normal controls (Table 3). There was no correlation between the changes of the lymphocyte subsets or NK cell activity and the mesangial cell ³[H]-thymidine uptake or the cytokine concentration including TNF α in PBMC culture supernatant (data not shown).

Table 3.

Lymphocyte Subsets and NK Cell Activity

DISCUSSION

Since Jones’ first report that monocytes/macrophages might be involved in the pathogenesis of glomerulonephritis⁹⁾, many immunocytochemical, enzyme cytochemical, and electron microscopic studies have been performed to identify the monocytes/macrophages in the glomeruli of various types of human and experimental glomerulonephritis^10–15). The reports for occurrence of monocytes/macrophages in the glomeruli of IgA nephropathy were variable, perhaps because of the difficulty in detecting monocytes/macrophages in the tissue^10–15). Arima et al⁶⁾ examined a specimen of renal biopsy by the indirect immunoperoxidase method, using anti-human monoclonal antibodies, and by ultrastructural peroxidase cytochemistry to clarify the significance of mononuclear phagocytes in IgA nephropathy, and suggested that mononuclear phagocytes might play an important role in the pathogenesis of mesangial hypercellularity in IgA nephropathy. The mononuclear cell has been known as one of the principal effectors cells leading to regulation of various cellular functions by infiltrating the glomerular mesangium and secreting various cytokines including IL-1, IL-6, PDGF and TNF α in immune mediated nephritis^5,7,16,19). it was reported that antibodies directed against monocytes might have a beneficial effect on human nephritis¹⁸⁾. The mesangial cell proliferation might be affected by inflammatory cytokines, such as IL-1, TNF α and IL-6, secreted from infiltrating mononuclear cells or from intrinsic glomerular cells in IgA nephropathy. However, there has been no consistency about the mitogenic or antimitogenic activity of TNF α on the mesangial cell in vitro as well as in vivo.

The results of the present study that mitogen stimulated PBMC culture supernatant of IgA nephropathy induce more ³[H]-thymidine into mesangial cell than that of normal controls, and that dilution of supernatant decreased the ³[H]-thymidine uptake into mesangial cell in IgA nephropathy suggest that the mononuclear cells of IgA nephropathy may have an intrinsic property to produce more cytokines which are mitogenic to mesangial cells and/or to produce less antimitogenic cytokines than that of normal controls. This is consistent with the previous report that the inflammatory cell, such as monocyte or macrophage, may infiltrate the glomerulus in response to inflammation or infection, and that its secreted products act as a mitogen to mesangial cell¹⁹⁾.

In the animal model of nephritis, TNF α can exacerbate proteinuria and accelerate renal disease^20–21). TNF α is known to induce changes in renal endothelial and mesangial cells^22,23), induce the expression of major histocompatibility complex class I, II and intercellular adhesion molecule-1^24,25) and induce the release of other potentially harmful cytokines²⁶⁾ or vasoactive factors²⁷⁾ that may increase the cytotoxic potential of resident glomerular macrophages. The production of TNF α may be primarily from the resident monocyte/macrophage and the glomerular mesangial cell, and such production has been postulated to play a role in glomerular damage^28–32).

The amount of TNF α mRNA in PBMC from patients with periarteritis nodosa and Wegener’s granulomatosis was reported to be increased compared with healthy subjects³³⁾. PBMC from patients with idiopathic nephritic syndrome in relapse also produced higher amounts of TNF α than those from healthy control children, and patients in remission or being treated with prednisone or cyclosporine had a TNF α production similar to or only slightly higher than controls³⁴⁾ Recently, in one study performed to investigate the role of cytokines in the mediation of glomerular injury in the nephritic syndrome caused by minimal change nephropathy, focal and segmental glomerulosclerosis and membranous nephropathy, mitogen-stimulated PBMC of nephritic subjects released an excess TNF α compared with controls, a response not consistently observed for IL-1 β, IL-2, IFN-α, and IFN-γ³⁵⁾.

For the effects of TNF α on mesangial cells, reports have provided conflicting results. Yamamoto et al³⁶⁾ suggested that TNF α augmented the proliferation of rat mesangial cells in the presence of 5% fetal bovine serum. By contrast, Floege et al⁵⁾ suggested that TNF α had growth inhibitory activity. Most of these equivocal results are likely to arise from differences of species or culture condition⁵⁾. It is suggested that the mitogenic effect of TNF α was low-grade when compared with other growth factors such as PDGF and was only observed at relatively high concentrations of the stimulus⁵⁾.

This study shows that supernatant from mitogen-stimulated PBMC of patients with IgA nephropathy contains higher concentration of TNF α compared with normal controls and that there was good correlation between the concentration of TNF α in supernatants and the ³[H]-thymidine uptake of mesangial cells. The result of this study is consistent with that of Yamamoto et al and suggests that the TNF α secreted from mitogen-stimulated PBMC may be the stimulatory factor for the mesangial cells.

Recent study on the effects of environmental lections on some cytokines synthesis in cultured rat mesangial cells showed that TNF release was maximally enhanced in comparison to untreated cells with ConA at the concentration of 100 μg/ml³⁷⁾. In this study, PBMC were stimulated with the ConA at the concentration of 10 μg/ml and the PHA of 20 μg/ml. although the concentration of TNF α in the supernatants from PBMC was not measured in the absence of these mitogens, and less amount of ConA was added to the PBMC culture. ConA and/or PHA might have an influence on the elevated concentration of TNF α in the supernatant.

PDGF has been known as one of the most potent mesangial cell mitogens⁴⁾. In this study, the concentration of PDGF in PBMC culture supernatant of IgA nephropathy was higher than that of normal controls. However, the difference of the concentration between them was not statistically significant. So, the role of PDGF on the increased ³[H]-thymidine uptake cannot be determined in this study. IL-2 has an autocrine function for the T cells and is suggested to play some roles in the pathogenesis of immunological disorder^38,44). However, it is uncertain whether this cytokine is mitogenic for mesangial cells or not. Authors previously observed that IL-2 activity of PHA-stimulated PBMC culture supernatant in IgA nephropathy was higher than that of normal controls⁴⁴⁾. In this study, the IL-2 concentration measured by radioimmunoassay in PBMC culture supernatant in IgA nephropathy was not higher than that in normal controls. Taken together, it’s suggested that IL-2 may not be the main factor for the mesangial cell proliferation. It is known that IFN-γ is an immune regulating factor against viral infection. Because some patients with IgA nephropathy have unspecified viral infection of the upper respiratory or gastrointestinal tract, it can be said that IFN-γ may be related to the pathogenesis of IgA nephropathy. However, we did not find the increased production of IFN-γ by PBMC from IgA nephropathy.

Studies on the T cell subsets in peripheral blood of the patients with IgA nephroapthy have reported somewhat contradictory results. Some reports have showed the increased percentages of CD4 cells and CD4/CD8 ratio as well as the reduced percentages of CD8^39,40), while no abnormalities in the percentages of CD4 cells, CD8 cells and CD4/CD8 ratio were observed by others^41,42). This study shows the reduced percentages of CD8 as well as the increased percentages of CD4/CD8 ratio. These results suggest that defective immune suppression caused by the decreased activity of CD8 cell may be related to the pathogenesis of IgA nephropathy.

It has been proposed that NK cells play an important role in surveillance mechanisms postulated to provide resistance against tumor and viral infections⁴³⁾. Because there is a close temporal relationship between the onset of IgA nephropathy and the upper respiratory infection in IgA nephropathy, the measurement of NK cell activity in this disease may be somewhat interesting. Our previous study showed that NK cell activity of the patients with IgA nephropathy was significantly higher than that of healthy controls⁴⁴⁾, and the result of this study was consistent with the previous finding.

In conclusion, these data suggested that mononuclear cell of IgA nephropathy may have the intrinsic property to produce more TNF α, when stimulated by mitogen, which might be related to the mesangial cell proliferation in IgA nephropathy, and the potential role of PBMC as active producers of cytokines relevant for mesangial cell proliferation.

References

1. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States. Am J Med 84:129. 1988;

2. D’Amico G. The commonest glomerulonephritis in the world; IgA nephropathy. Q J Med 64:709. 1987;

3. Kim MJ, Lim CG, Cho BS, Kim YW, Yang MH. A histopathological study of IgA nephropathy. Kor J Nephrol 4:197. 1985;

4. Choi IJ, Jeong HJ, Han DS, Lee JS, Lee Hy, Kim PK. An analysis of 2361 cases of renal biopsy in Korea. Yonsei Medical Journal 32:9. 1991;

5. Floege J, Topley N, Resoh K. Regulation of mesangial cell proliferation. Am J Kidney Dis 17:673. 1991;

6. Arima S, Nakayama M, Naito M, Sato T, Takahashi K. Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 39:684. 1991;

7. Vissers M, Fantone JC, Wiggins R, Kungel SL. Glomerular basement membrane containing immune complexes stimulate TNF and interleukin 1 production by human monocytes. Am J Pathol 134:1. 1989;

8. Boyum A. Separation of leukocytes from blood and bone marrow with spedial reference to factors which influence and modify sedimentation properties of hematopoietic cells. Scand J Clin Lab Invest 21(Suppl 97):7. 1968;

9. Jones DB. Inflammation and repair of the glomerulus. Am J Pathol 27:991. 1951;

10. Atkins RC, Holdsworth SR, Hancock WW, Thomson NM, Glasgow EF. Cellular immune mechanisms in human glomerulonephritis: The role of mononuclear leukocytes. Springer Semin Immunopathol 5:269. 1982;

11. Ferrario F, Castiglione A, Colasant G, Belgioiso GB, Bertoli S, D’Amico G. The detection of monocytes in human glomerulonephritis. Kidney Int 28:513. 1985;

12. Boucher A, Droz D, Adafer E, Noel LH. Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 29:1043. 1986;

13. Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964. 1987;

14. Nolasco FFB, Cameron JS, Hartley B, Coelho A, Hildreth G, Reuben R. Intraglomerular T cell and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31:1160. 1987;

15. Thomson NH, Holdsworth SR, Glasgow EF, Atkins RC. The macrophage in the development of experimental crescentic glomerulonephritis. Am J Pathol 94:223. 1979;

16. Hariharan S, Hong SY, Hsu A, McCarthy EP, Gastside PS, Ool BS. Effect of 1, 25-dihydroxy-vitamin D₃ on mesangial cell proliferation. J Lab Clin Med 117:423. 1991;

17. Wardle NE. Cytokine growth factors and glomerulonephritis. Nephron 57:257. 1991;

18. Johnson RB. Monocytes and macrophages. N Engl J Med 318:747. 1988;

19. Schreiner GF. The role of the macrophage in glomerular injury. Semin Nephrol 11:268. 1991;

20. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 134:419. 1989;

21. Brennan DC, Yue MA, Wuthrich RP, Kelley VE. Tumor necrosis factor and IL-1 in New Zealand black/white mice. J Immunol 143:419. 1989;

22. Cotran RS, Pober JS. Effect of cytokines on vascular endothelium. Their role in vascular and immune injury. Kidney Int 35:969. 1989;

23. Cavender DE, Edelbaum D, Ziff M. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol 134:551. 1989;

24. Brennan DC, Jevnikar AM, Takei F, Reubin-Kelley VE. Mesangial cell accessory functions: Mediation by intercellular adhesion molecule-1. Kidney Int 38:1038. 1990;

25. Wedgwood JFF, Hatam L, Bonagura VR. Effect of interferon gamma and tumor necrosis factor on the expression of class I and II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Cell Immunol 111:1. 1988;

26. Mawroth PP, Bank I, Handely D, Cassimeris J, Chess L, Stern D. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 166:1390. 1987;

27. Marsden PA, Ballermann BJ. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L arginine-dependent mechanism. J Exp Med 43:1843. 1990;

28. Noble B, Ren K, Taverne J, Dipirro J, Van Liew J, Dijkstra C, Janossy G, Poulter LW. Mononulcear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol 80:281. 1990;

29. Baud L, Oudinet JP, Bens M, Now L, Peraldi MN, Rondeau E, Etienne J, Ardaillou R. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35:1111. 1989;

30. Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am J Physiol 257:399. 1989;

31. Vissers MC, Fantone JC, Wiggins R, Kunkel SL. Glomerular basement membrane containing immune complexes stimulate tumor necrosis factor and interleukin-1 production by human monocytes. Am J Pathol 134:1. 1989;

32. Boswell JM, Yui MA, Burt Dw, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol 141:3050. 1988;

33. Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K, Kitamoto K, Nagasawa T, Suzuki K. Pathogenesis of anti-myeloperoxidase antibodies related creascentic glomerulonephritis. (Abstract). J Am Soc Nehprol 2:262. 1991;

34. Bustos C, gomez-Chiarri M, Gonzalez E, Muley R, Egido J. Increased plasma levels and monocytes production of tumor necrosis factor in patient with idiopathic nephrotic syndrome. (Abstract). J Am Soc Nephrol 2:262. 1991;

35. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kid Dis 21:251. 1993;

36. Yammamoto T, Yaoita E, Kawasaki K, Kihara I. Tumor necrosis factor (TNF) augments proliferation of rat mesangial cells (RMC). (Abstract). Kidney Int 35:367. 1989;

37. Amore A, Cavallo F, Bocchietto E, Bussolino F, Gianoglio B, Peruzzi L, Porcellini MG, Coppo R. Cytokine mRNA expression by cultured rat mesangial cells after contact with environmental lectins. Kidney Int 43(Suppl 39):5–41. 1993;

38. Luger TA, Smolen JS, Chused TM, Steinberg AD, Oppenheim JJ. Human lymphocytes with either OKT4⁺ and OKT8⁺ phenotype produced IL-2 in culture. J Clin Invest 70:470. 1982;

39. Chatenoud L, Bach M. Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosus. Kidney Int 20:267. 1981;

40. Egido J, Blasco R, Sancho J, Lozano L. T-cell dysfunctions in IgA nephropathy; Specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol 26:201. 1983;

41. Lai KN, Lai FM-M, Chui SH, Leung KN, Lam CWK. Effect of ciclosporin on lymphocyte subpopulations and immunoglobulin production in IgA nephropathy. Nephron 52:307. 1989;

42. Lai KN, Lai FM-M, Chui SH. Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy? Clin Nephrol 28:281. 1987;

43. Herberman RB. Immune surveillance hypothesis: Updated formulation and possible effectors mechanisms. Immunology In : Yamamura Y, ed. New York: Academic Press; 1983. p. 1157.

44. Lee TW, Kim MJ. Production of interleukin-2(IL-2) and expression of IL-2 receptor in patients with IgA nephropathy. Kor J Int Med 7:31. 1992;

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

	Mean	Range
Sex (M/F)	7/3
Age (years)	30.1 ± 3.1	16–47
Serum creatinine (mg/dl)	0.99 ± 0.97	0.5–1.3
Serum albumin (mg/dl)	4.5 ± 0.1	3.8–4.8
Serum IgA (mg/dl)	260.8 ± 24.0	168–387

	IgAN	Normal	Significance (P)
Lymphocyte (/ul)	2673 ± 174	2709 ± 182	NS^a
CD₃ cell (%)	71.8 ± 2.0	85.1 ± 3.6	0.012
CD₄ cell (%)	40.9 ± 4.0	41.0 ± 2.7	NS
CD₈ cell (%)	26.2 ± 2.4	36.0 ± 8.9	0.046
CD₄/CD₈	1.83+ 0.24	1.19 ± 0.13	0.034
B cell (%)	8.9 ± 1.4	4.8 ± 0.8	0.026
NK cell activity (%)	47.2 ± 3.3	17.8 ± 5.9	0.003